Intellectual Property
Our IP Team, which has grown steadily since the 1990s, comprises some of Switzerland’s leading intellectual property law lawyers, covering all aspects of patent, know-how, trademark, copyright, design and unfair competition law. This includes clarifying the noninfringement of third-party rights, management of worldwide IP portfolios, exploitation and enforcement of intellectual property rights and defense against infringement allegations, both out of court and before state courts and arbitratral tribunals. Our well experienced team has the specialised expertise and human resources to help our Swiss and foreign clients succeed. We typically work in an international context. We follow the important legal, economic and technical developments in Switzerland and worldwide and often help shape them. Innovative companies, whether small, medium-sized or large, usually either have us on their side or as an opponent.
Our team offers you access to experts especially in these areas:
Our team represents and advises international and Swiss clients in all fields of trademark and design law.
MoreMLL’s long-standing and widely respected copyright and media team has specialised expertise concerning issues of copyright and media law in addition to in-depth knowledge of new media and related technologies.
MoreThe legal field of protected geographical indications has massively gained in significance in recent years.
MoreTeam
- Nicola Benz
- Renato Bucher
- Ulrike Ciesla
- Guillaume Fournier
- Louisa Galbraith
- Jacques Johner
- Stefan J. Schröter
- Kilian Schärli
- Nadine von Büren-Maier
- Reinhard Oertli
- Daniel Donauer
- Andrea Heiniger
- Andrea Schäffler
- Yannick Tschudi
- Ada Sofie Altobelli
- Linda Cetkovic
- Nadia Fiechter
- Timmy Pielmeier
- Franziska Schweizer
- Rhea Specogna
- Clara Weill
“Excellent law firm, with outstanding partners and associates in all areas of IP. It is a pleasure working with them, my preferred choice in Switzerland”
Publications
Swiss Federal Supreme Court confirms validity of Bristol-Myers Squibb’s SPC for apixaban
Bristol-Myers Squibb successfully defended the Swiss SPC for the pharmaceutical active ingredient apixaban, used in the blockbuster anticoagulant Eliquis.- EN
Die Nutzung fremder Marken zur Suchmaschinenoptimierung
4 | 2024 sic! Stiftung, Bern / Helbing Lichtenhahn Verlag, Basel- DE
- Stefan J. Schröter
- Timmy Pielmeier
- Lars Scheuner
Legal 500: Patent Litigation Comparative Guide
The Legal 500 Country Comparative Guides 2024, October 2024- EN
Value of a Photograph
Value of a Photograph Vortrag während INGRES Kongress, 02.07.2024- DE